Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians

Background: Injection drug use-associated bacterial and viral infections are increasing. Expanding access to harm reduction services, such as safe injection education, are effective prevention strategies. However, these strategies have had limited uptake. New tools are needed to improve provider cap...

Full description

Bibliographic Details
Main Authors: Boudreau, J. (Author), Branch-Elliman, W. (Author), Gifford, A.L (Author), Harvey, L. (Author), Hyde, J. (Author), Linsenmeyer, K. (Author), Sliwinski, S.K (Author), Strymish, J. (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03834nam a2200673Ia 4500
001 10-1093-ofid-ofab631
008 220420s2022 CNT 000 0 und d
020 |a 23288957 (ISSN) 
245 1 0 |a Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians 
260 0 |b Oxford University Press  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1093/ofid/ofab631 
520 3 |a Background: Injection drug use-associated bacterial and viral infections are increasing. Expanding access to harm reduction services, such as safe injection education, are effective prevention strategies. However, these strategies have had limited uptake. New tools are needed to improve provider capacity to facilitate dissemination of these evidence-based interventions. Methods: The "Six Moments of Infection Prevention in Injection Drug Use"provider educational tool was developed using a global, rather than pathogen-specific, infection prevention framework, highlighting the prevention of invasive bacterial and fungal infections in additional to viral pathogens. The tool's effectiveness was tested using a short, paired pre/post survey that assessed provider knowledge and attitudes about harm reduction. Results: Seventy-five respondents completed the paired surveys. At baseline, 17 respondents (22.6%) indicated that they had received no prior training in harm reduction and 28 (37.3%) reported discomfort counseling people who inject drugs (PWID). Sixty respondents (80.0%) reported they had never referred a patient to a syringe service program (SSP); of those, 73.3% cited lack of knowledge regarding locations of SSPs and 40.0% reported not knowing where to access information regarding SSPs. After the training, 66 (88.0%) reported that they felt more comfortable educating PWID (P < .0001), 65 respondents (86.6%) reported they planned to use the Six Moments model in their own practice, and 100% said they would consider referring patients to an SSP in the future. Conclusions: The Six Moments model emphasizes the importance of a global approach to infection prevention and harm reduction. This educational intervention can be used as part of a bundle of implementation strategies to reduce morbidity and mortality in PWID. © 2022 Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022. 
650 0 4 |a adult 
650 0 4 |a Article 
650 0 4 |a bacterial infection 
650 0 4 |a Candida 
650 0 4 |a counseling 
650 0 4 |a data analysis 
650 0 4 |a disease transmission 
650 0 4 |a drug use 
650 0 4 |a education 
650 0 4 |a education program 
650 0 4 |a endotoxin 
650 0 4 |a female 
650 0 4 |a harm reduction 
650 0 4 |a health care personnel 
650 0 4 |a health survey 
650 0 4 |a hospital infection 
650 0 4 |a human 
650 0 4 |a immunization 
650 0 4 |a infection control 
650 0 4 |a infection control 
650 0 4 |a infection prevention 
650 0 4 |a infection prevention 
650 0 4 |a infectious agent 
650 0 4 |a knowledge 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a medical education 
650 0 4 |a medical education 
650 0 4 |a mycosis 
650 0 4 |a patient care 
650 0 4 |a patient satisfaction 
650 0 4 |a prevalence 
650 0 4 |a PWID 
650 0 4 |a questionnaire 
650 0 4 |a skin flora 
650 0 4 |a Streptococcus 
650 0 4 |a training 
650 0 4 |a World Health Organization 
700 1 0 |a Boudreau, J.  |e author 
700 1 0 |a Branch-Elliman, W.  |e author 
700 1 0 |a Gifford, A.L.  |e author 
700 1 0 |a Harvey, L.  |e author 
700 1 0 |a Hyde, J.  |e author 
700 1 0 |a Linsenmeyer, K.  |e author 
700 1 0 |a Sliwinski, S.K.  |e author 
700 1 0 |a Strymish, J.  |e author 
773 |t Open Forum Infectious Diseases